Intra-community spatial variability of particulate matter size distributions in southern California/Los Angeles

International audienceUltrafine particle (UFP) number concentrations vary significantly on small spatial and temporal scales due to their short atmospheric lifetimes and multiplicity of sources. To determine UFP exposure gradients within a community, simultaneous particle number concentration measurements at a network of sites are necessary. Concurrent particle size distribution measurements aid in identifying UFP sources, while providing data to investigate local scale effects of both photochemical and physical processes on UFP. From April to December 2007, we monitored particle size distributions at 13 sites within 350 m to 11 km of each other in the vicinity of the Ports of Los Angeles and Long Beach using Scanning Mobility Particle Sizers (SMPS). Typically, three SMPS units were simultaneously deployed and rotated among sites at 1?2 week intervals. Total particle number concentration measurements were conducted continuously at all sites. Seasonal and diurnal size distribution patterns are complex, highly dependent on local meteorology, nearby PM sources, and times of day, and cannot be generalized over the study area nor inferred from one or two sampling locations. Spatial variation in particle number size distributions was assessed by calculating the coefficient of divergence (COD) and correlation coefficients (r) between site pairs. Results show an overall inverse relationship between particle size and CODs, implying that number concentrations of smaller particles (<40 nm) differ from site to site, whereas larger particles tend to have similar concentrations at various sampling locations. In addition, variations in r values as a function of particle size are not necessarily consistent with corresponding COD values, indicating that using results from correlation analysis alone may not accurately assess spatial variability

Syncytiotrophoblast Microvesicles Released from Pre-Eclampsia Placentae Exhibit Increased Tissue Factor Activity

Background: Pre-eclampsia is a complication of pregnancy associated with activation of coagulation. It is caused by the placenta, which sheds increased amounts of syncytiotrophoblast microvesicles (STBM) into the maternal circulation. We hypothesized that STBM could contribute to the haemostatic activation observed in pre-eclampsia. Methodology/Principal Findings: STBM were collected by perfusion of the maternal side of placentae from healthy pregnant women and women with pre-eclampsia at caesarean section. Calibrated automated thrombography was used to assess thrombin generation triggered by STBM-borne tissue factor in platelet poor plasma (PPP). No thrombin was detected in PPP alone but the addition of STBM initiated thrombin generation in 14/16 cases. Pre-eclampsia STBM significantly shortened the lag time (LagT, P = 0.01) and time to peak thrombin generation (TTP, P = 0.005) when compared to normal STBM. Blockade of tissue factor eliminated thrombin generation, while inhibition of tissue factor pathway inhibitor significantly shortened LagT (p = 0.01) and TTP (P,0.0001), with a concomitant increase in endogenous thrombin potential. Conclusions/Significance: STBM triggered thrombin generation in normal plasma in a tissue factor dependent manner, indicating that TF activity is expressed by STBM. This is more pronounced in STBM shed from pre-eclampsia placentae. As more STBM are shed in pre-eclampsia these observations give insight into the disordered haemostasis observed in thi

P2X7 receptor signaling contributes to tissue factor–dependent thrombosis in mice

Thrombosis is initiated by tissue factor (TF), a coagulation cofactor/receptor expressed in the vessel wall, on myeloid cells, and on microparticles (MPs) with variable procoagulant activity. However, the molecular pathways that generate prothrombotic TF in vivo are poorly defined. The oxidoreductase protein disulfide isomerase (PDI) is thought to be involved in the activation of TF. Here, we found that in mouse myeloid cells, ATP-triggered signaling through purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7 receptor; encoded by P2rx7) induced activation (decryption) of TF procoagulant activity and promoted release of TF+ MPs from macrophages and SMCs. The generation of prothrombotic MPs required P2X7 receptor–dependent production of ROS leading to increased availability of solvent-accessible extracellular thiols. An antibody to PDI with antithrombotic activity in vivo attenuated the release of procoagulant MPs. In addition, P2rx7–/– mice were protected from TF-dependent FeCl3-induced carotid artery thrombosis. BM chimeras revealed that P2X7 receptor prothrombotic function was present in both hematopoietic and vessel wall compartments. In contrast, an alternative anti-PDI antibody showed activities consistent with cellular activation typically induced by P2X7 receptor signaling. This anti-PDI antibody restored TF-dependent thrombosis in P2rx7–/– mice. These data suggest that PDI regulates a critical P2X7 receptor–dependent signaling pathway that generates prothrombotic TF, defining a link between inflammation and thrombosis with potential implications for antithrombotic therapy